Tadalafil tablets

Tadalafil tablets

Learn about tadalafil (Cialis) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. Tadalafil is a phosphodiesterase inhibitor used for treating impotence (erectile dysfunction, or ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension (PAH). Tadalafil is available under the following different brand names: Adcirca, and Cialis. 8.1 Pregnancy Risk Summary - Tadalafil is not indicated for use in females. There are no data with the use of tadalafil tablets in pregnant women to inform any drug-associated risks for. Tadalafil is also used in both men and women to treat the symptoms of pulmonary arterial hypertension to improve your ability to exercise. This is high blood pressure that occurs in the main artery that carries blood from the right side of the heart (the ventricle) to the lungs. Easy-to-read patient leaflet for Tadalafil Tablets (Cialis). Includes indications, proper use, special instructions, precautions, and possible side effects. Tadalafil is a generic prescription drug used for erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. It comes as a tablet that you take either once per day or. Tadalafil increases blood flow to particular areas of the body and is used to treat erectile dysfunction. Learn about side effects, interactions and indications. Tadalafil tablets USP, 2.5 mg are supplied as white to off-white, round, biconvex, film-coated tablets debossed with “C1” on one side and plain on the other. Tadalafil tablets USP, 5 mg are. Tadalafil is a generic drug prescribed for erectile dysfunction and other conditions. Learn about the drug’s dosages, form, strengths, and more. Find patient medical information for Tadalafil (Cialis, Adcirca, and others) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings.

Leave a Reply

Your email address will not be published. Required fields are marked *

*
*